GlassScriptPhysician profile
Rex Albert Fletcher
NPI 1205858834
$1,018.38
in general payments reported to CMS, 2019-2025
17 companies · $50.19 in 2025
The $50.19 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $36.96 · 2021: $311 · 2022: $99.70 · 2023: $185 · 2024: $87.89 · 2025: $50.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $323.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $210.17 | 2021-2024 | |
| Glaxosmithkline, LLC. | $133.75 | 2021-2023 | Bexsero, Pediarix, Rotarix |
| Medline Industries LP | $119.08 | 2019 | |
| Corium, LLC | $111.85 | 2021-2024 | Azstarys |
| Supernus Pharmaceuticals, INC. | $79.92 | 2021-2024 | Qelbree |
| Sanofi Pasteur INC. | $69.19 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.76 | 2019-2021 | |
| Genentech USA, INC. | $35.32 | 2019 | |
| Ironshore Pharmaceuticals INC. | $35.04 | 2022 | |
| Sobi, INC | $29.48 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $25.97 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $20.98 | 2024 | Zoryve |
| Biomarin Pharmaceutical INC. | $20.69 | 2023 | Voxzogo 1.2mg |
| Vertical Pharmaceuticals, LLC | $20.04 | 2020 | |
| Shire North American Group INC | $18.70 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $17.60 | 2023 | Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $16.84 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rex Fletcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.